-+ 0.00%
-+ 0.00%
-+ 0.00%

Amylyx Pharma Q3 EPS $(0.38), Inline

Benzinga·11/05/2026 12:00:42
Listen to the news
Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate. This is a 2.7 percent decrease over losses of $(0.37) per share from the same period last year.